CliffBio
small molecule

ISMOTIC

ISOSORBIDE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameISMOTIC
Active ingredientISOSORBIDE
Strength100GM/220ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ISMOTIC patent cliff — loss of exclusivity — | CliffBio